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CHAPTER I 
INTRODUCTION 
Coronary heart disease has been identified as the major 
cause of death in the United States. Atherosclerosis has 
been implicated in the majority of these cases. Individuals 
with elevated levels of blood cholesterol (hypercholesterol-
emia) are considered to be at higher risk for developing 
atherosclerosis than those with normal levels. Thus 
individuals having hypercholesterolemia use medication or 
dietary modification in order to reduce serum cholesterol 
levels. The reductions achieved by dietary modifications 
may be minimal and most forms of medication currently used 
have undesirable side effects. 
Lactobacillus acidophilus has been found to assimilate 
cholesterol under conditions expected to occur in the 
gastrointestinal tract. The cholesterol is apparently 
incorporated into the bacterial cells. Consumption of cells 
of selected strains of L. acidophilus can thus be beneficial 
in helping control the absorption of cholesterol from the 
intestine into the blood. Consumption of whey as well as 
other dairy products has also been shown to decrease blood 
cholesterol levels in humans and in animals. 
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If consumption of ~· acidophilus alone or in 
conjunction with whey will lower serum cholesterol levels, 
this may provide an excellent method for individuals to 
reduce their risk of coronary heart disease. The purpose of 
this study was to evaluate the young growing pig as an 
animal model to examine the effects of consuming cells of L. 
acidophilus alone or in conjunction with dried whey on serum 
cholesterol levels. 
CHAPTER II 
REVIEW OF LITERATURE 
Role of Cholesterol 
in the Body 
Cholesterol is a natural and required component of the 
human body (63). The body uses cholesterol as a precursor 
for the steroid hormones, bile salts, and vitamin D. It 
also is incorporated into all cell membranes where it is 
involved in the regulation of membrane fluidity. 
Cholesterol is acquired by synthesis, which occurs primarily 
in the liver and in limited amounts in the intestine, or by 
absorbing undigested cholesterol from dietary sources. The 
synthesis of cholesterol is controlled by a feedback 
mechanism (63). Dietary cholesterol suppresses the 
synthesis of 3-hydroxy-3-methylglutaryl CoA reductase which 
catalyzes the committing step of cholesterol synthesis (11). 
Within the body, specific plasma lipoprotein complexes 
transport cholesterol and cholesterol esters as well as 
other lipids. The complexes categorized based on their 
densities include: chylomicrons (<0.94 g/cm3), very-low-
density lipoproteins (VLDL) (0.94-1.006 g/cm3), low-density 
lipoproteins (LDL) (1.006-1.063 g/cm3), and high-density 
lipoproteins (HDL) (1.063-1.210 g/cm3 ) (63). The LDL 
3 
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complexes transport from one-half to two-thirds of the 
plasma cholesterol including both free and esterif ied forms 
(22). Unlike the LDL complexes, the HDL-cholesterol 
complexes contain only unesterified cholesterol (22). It 
has long been recognized that accelerated atherosclerosis is 
associated with the elevation of low-density lipoprotein 
cholesterol levels in the blood (18). 
The low-density lipoproteins transport plasma 
cholesterol to non-hepatic tissues where specific receptors 
on cell membranes bind the LDL particles which allows the 
cells to take in the cholesterol complex (20). Excess 
cholesterol in a cell suppresses endogenous synthesis and 
may be re-esterified and stored. The high-density 
lipoproteins appear to transport cholesterol away from 
peripheral tissue to the liver for excretion (45). 
Cholesterol and Coronary 
Heart Disease 
The major cause of death in the United States is 
cardiovascular disease, which accounts for 49% of all deaths 
(67). The underlying cause of most cardiovascular disease 
is atherosclerosis (30,49). Atherosclerosis is an irregular 
thickening of the inner wall of the arteries that reduces 
the size of the lumen. The thickening is caused by the 
accumulation of plaque which consists of smooth muscle 
cells, connective tissue, and considerable deposits of lipid 
of which cholesteryl esters comprise the major part (20). 
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The most commonly used methods for decreasing the risk 
of coronary heart disease involve lowering blood cholesterol 
levels (22) by altering diets, administering drugs or both. 
However, both of these methods have limitations or 
repercussions. Many individuals have difficulty maintaining 
a low fat diet, and even more important, none of the drugs 
used for lowering blood cholesterol levels are without 
biochemical or systemic side effects (22). 
Elevated levels of total cholesterol and low-density 
lipoprotein cholesterol increase the risk of coronary heart 
disease (21). A significant relationship exists between 
coronary heart disease and both cholesterol intake and 
plasma cholesterol levels (32). Much evidence suggests that 
the low density lipoprotein complexes are involved in 
atherogenesis (34, 35, 68), the basic process responsible 
for coronary heart disease (61). A report by the Lipid 
Research Clinic's Program (36, 37) from a seven year trial 
concludes that lowering total plasma cholesterol as well as 
low-density cholesterol could significantly reduce the risk 
of coronary heart disease (24%) or myocardial infarction 
(19%). 
Hypocholesterolemic Effects of 
Milk, Mi~k Products, and 
Cultured Milk Products 
Since the work by Mann and Spoerry (43) on the 
hypocholesterolemic effect of a cultured milk product, there 
have been many reports of milk, milk products, and cultured 
milk products producing hypocholestrolemic effects in 
humans, pigs, rabbits, and rats. Several milk fractions or 
constituents have been shown to produce a hypocholesterol-
emic effect. The constituents proposed as the responsible 
factors include 3-hydroxy-3-methylglutarate (HMG) (41, 48), 
erotic acid (1, 4, 5), calcium (28) ,and lactose (25). 
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Orotic acid and 3-hydroxy-3-methylglutarate appear to 
exert their action by inhibiting cholesterol synthesis. In 
vitro and in vivo studies have shown that HMG (3) and erotic 
acid (4, 5) inhibit cholesterol synthesis from acetate in 
rat liver preparations. 
Feeding trials using whey, skim milk, whole milk and 
yogurt have resulted in lowering of blood cholesterol levels 
in animals and human volunteers. Cultured products appear 
to produce more of an effect than do non-cultured products 
(23, 26, 41, 52, 54, 64). Levels of erotic acid in milk 
decrease during the fermentation of yogurt (51) and it is 
not known if HMG occurs in milk (54). These factors cannot 
account for the increased hypocholesterolemic effects of 
cultured milk products. 
Mann and Spoerry (43) used Maasai tribesmen to test 
the hypothesis that a surfactant in the diet would cause 
hypercholesterolemia. The Maasai normally consume a diet 
consisting primarily of fermented milk and meat yet they 
exhibit a low incidence of coronary heart disease (42). 
Twenty four volunteers were given their usual diet of 
fermented milk (fermented with a wild strain of 
Lactobacillus) for six days and on the seventh day, a steer 
was slaughtered and consumed. This was repeated for three 
weeks. The men were assigned to two treatment groups. For 
one the fermented milk was supplemented with a surfactant 
(Tween 20) and the other a placebo (pure olive oil). Both 
treatment groups, with and without a surfactant exhibited 
significant reductions in serum cholesterol levels during 
the three week trial. As milk consumption increased, as 
indicated by weight gain, serum cholesterol levels 
decreased. This was contrary to what was expected since 
their diet contained fat and cholesterol. This decrease in 
blood cholesterol was attributed to the consumption of the 
fermented milk. They concluded that some component of the 
fermented milk reduced serum cholesterol synthesis in the 
body 
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Mann (41) confirmed his previous report by showing that 
consumption of skim and whole milk yogurt resulted in 
reduced (P<0.05) serum cholesterol levels in humans during 
the twelve day trial. Synthesis of cholesterol from orally 
administered radioacetate was also reduced in human subjects 
consuming yogurt. Blood cholesterol levels slowly returned 
to normal after consumption of yogurt ceased. Whole fresh 
milk did not cause a reduction in blood cholesterol levels. 
Fifty-four volunteers were used to test the effect of 
supplementing the diet with non-pasteurized yogurt, 
pasteurized yogurt, and 2 percent fat milk by Hepner et al. 
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(26). Both pasteurized and non-pasteurized yogurt 
significantly reduced serum cholesterol levels (P<0.01) 
during a twelve week trial where the diet was constantly 
supplemented with the milk products. Consumption of 2 
percent fat milk caused a smaller reduction (P<0.05) in 
serum cholesterol levels than did supplementation with 
yogurt. Serum triglycerides were not significantly effected 
by any of the treatments. 
In a report by Howard and Marks (29), both skim milk 
(P<0.001) and whole milk (P<0.01) exerted a significant 
hypocholesterolemic response on blood cholesterol in sixteen 
human volunteers. Seven volunteers receiving 2.4g calcium 
(calcium gluconate) (equivalent to 4 pints of milk) daily 
for 12 days did not exhibit any change in blood cholesterol 
levels, suggesting that calcium was not the hypocholesterol-
emic component. 
Thompson (65) and Massey (44) saw no reduction in blood 
cholesterol levels of humans consuming fermented or non-
fermented milk products. However, they saw no increase 
either, which might have been expected from the increases in 
fat and cholesterol intake which occurred in their studies. 
Stahelin et al. (60) supplemented the high fat diet of 
growing swine with skim milk, yogurt, whey, fermented whey, 
casein, and lactose. During a five week trial, skim milk, 
whey, fermented whey, and yogurt lowered blood cholesterol 
levels compared to a high fat control diet. Only the effect 
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of the skim milk was significant. Lactose and casein had no 
effect on cholesterol levels. 
The effect of whey and specific whey fractions on blood 
cholesterol levels in growing swine was studied by Beames et 
al. (2). Whey, whey protein and lactose produced a trend 
for reduced serum cholesterol during an eight week trial 
although it was not significant. A time by treatment 
interaction (P<0.0001) made interpretation of the data 
difficult. 
Norton et al. (50) used four mature pigs to test the 
effect of whey on blood cholesterol levels with and without 
additional cholesterol supplementation. Pigs fed a diet 
supplemented with whey and cholesterol had a ·15% (P<0.001) 
lower serum cholesterol level than pigs on a control diet 
without whey. Serum HDL cholesterol was significantly 
higher (P<0.05) in pigs consuming whey than the pigs on a 
non-whey diet, indicating that most of the reduction in 
serum cholesterol occurred in the LDL+VLDL fractions. 
Thakur and Jha (64) found that serum cholesterol levels 
as well as the size of atherosclerotic lesions were reduced 
in rabbits fed a high cholesterol diet supplemented with 
milk, yogurt, and calcium. Yogurt and calcium reduced serum 
cholesterol levels to a greater extent than did milk 
(P<0.001). The lower level of serum cholesterol in the 
yogurt group than in the calcium group suggests that there 
may be hypocholestrolemic factors present other than 
calcium. 
The effect of adding skim milk powder or B-hydroxy-B-
methyl glutaric acid (HMG) to diets supplemented with 
cholesterol and fat for rats was studied by Nair and Mann 
(48). Rats which received skim milk powder and HMG with or 
with out cholesterol had reduced serum cholesterol compared 
to rats receiving control and control + cholesterol diets. 
The effect of the milk powder and HMG were similar. The 
authors suggested that the "Milk Factor" was HMG. 
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Supplementing the diets of rats with thermophilus milk 
(skim milk fermented by Streptococcus thermophilus) 
significantly reduced (P<0.05) total plasma cholesterol 
compared to control diets supplemented with water and skim 
milk in an investigation by Rao et al. (52). Consumption of 
diets supplemented with methanol solubles from whole milk 
fermented with Streptococcus thermophilus reduced plasma 
cholesterol (P<0.05) compared to diets supplemented with 
methanol solubles of nonferrnented whole milk. They further 
reported that methanol solubles from skim milk and 
thermophilus milk inhibited cholesterolgenesis from acetate 
by rat liver homogenates in vitro. 
Use of Lactobacillus acidophilus 
as a Dietary Adjunct to lower 
Serum Cholesterol 
Several lactobacilli are used as dietary adjuncts in 
that they are present in various cultured products. 
However, not all of the lactobacilli are able to survive and 
grow in the intestinal tract. Lactobacillus acidophilus 
normally inhabits the gastrointestinal tract of humans (7) 
where it can grow and help maintain a properly balanced 
microflora (13, 56, 57). 
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Several researchers have reported that the consumption 
of L. acidophilus resulted in lowered serum cholesterol 
levels. Torteuro (66) found that consumption of L. 
acidophilus by cecectornized and normal laying hens resulted 
in significantly lower blood cholesterol levels after one 
month. Harrison and Peate (24) found that human infants fed 
milk containing ~· acidophilus had at day eight, 
significantly lower serum cholesterol levels (P<0.001), 
greater weight gains (P<0.05), and an increase in numbers of 
lactobacilli in their stools (P<0.001) compared to those 
infants consuming an unaltered milk formula. They offered 
no suggestion as to how L. acidophilus effected the 
reduction in serum cholesterol levels. 
Mott (47) found that germ free pigs monocontaminated 
with L. acidophilus exhibited reduced serum cholesterol 
levels after subsequent development of a normal flora. This 
suggests that the intestinal flora can have a definite 
effect on blood cholesterol levels. Grunnewald (23) 
reported that rats fed milk fermented with L. acidophilus 
and methanol solubles from this fermented milk had lower 
serum cholesterol levels (p<0.05) compared to water or milk 
fed controls. She concluded that some factor was produced 
during fermentation of the milk which reduced cholesterol 
synthesis in the rats. 
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Gilliland et al. (14) reported that some strains of L. 
acidophilus could assimilate cholesterol from a defined 
laboratory growth medium. The presence of bile and growth 
under anaerobic conditions were required for assimilation. 
They also found that supplementing a high cholesterol diet 
of growing pigs with cells of a strain capable of assimilat-
ing cholesterol from a laboratory medium significantly 
influenced serum cholesterol levels. The pigs receiving the 
cholesterol assimilating strain of ~· acidophilus had 
significantly lower levels of serum cholesterol than did 
those receiving a non-cholesterol assimilating strain or the 
diet without any lactobacilli. 
Pigs as Experimental Models for 
Cardiovascular Research 
Pigs are one of the most suitable animal models for 
cardiovascular research. They have digestive and blood 
circulatory systems that are similar to humans, and they 
display atherosclerotic tendencies similar to humans (53). 
Diets high in cholesterol and fat induce increases in serum 
cholesterol levels (2, 10, 14, 50, 60) and aortic athero-
sclerosis (40, 15). The structure of the serum low-density 
lipoproteins and their apoproteins are similar in swine and 
humans (6, 12, 33, 39, 40). The lipoprotein receptors on 
liver membranes are similar in swine and humans (38). There 
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is a high correlation between aortic cholesterol and serum 
low-density lipoprotein levels in both swine and humans (27, 
59) • 
CHAPTER III 
MATERIALS AND METHODS 
Selection of Strains of Lactobacillus 
acidophilus for Pig Feeding Trials 
Strains of Lactobacillus acidophilus from the culture 
collection in the Dairy Foods Microbiology Laboratory at 
Oklahoma State University were screened as candidates for 
use as feed adjuncts in a pig feeding trial. The 14 strains 
were all isolates from swine intestines. The strains were 
screened for the the ability to assimilate cholesterol by 
the method of Gilliland et al. (14), except the assay broth 
contained 10 percent PPLO serum. The cholesterol 
assimilating ability of the cultures was based on the amount 
of cholesterol remaining in the spent broth following 24 hr 
of growth at 37°c. The method of Rudel and Morris (55) was 
used to quantitate cholesterol. 
The bile tolerance of each strain was measured by the 
procedure of Gilliland et al. (14). The time required for 
the absorbance at 600 nanometers to increase by 0.3 units 
for each culture was measured. 
The strains were also tested for antagonism against 
each other by the following procedure. One tenth ml of a 
14 
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freshly prepared lactobacilli MRS broth (Difeo) culture of 
each strain was added to 20 ml molten MRS agar (prepared by 
adding 1.5 percent Difeo Bacto-Agar to MRS broth prior to 
sterilization) tempered to 45°c. Five ml of the seeded agar 
was added to each of three sterile petri dishes. Spent 
broth from an 18 hour MRS broth culture of each strain was 
adjusted to pH 6.5 with 1.0 N NaOH and filter sterilized 
into sterile screw cap tubes using Acrodisc filters with 
0.45 micron pore size (Gelman Sciences Ann Arbor MI). 
Sterile paper discs (13 mm diameter} were saturated with the 
filter sterilized spent broth and placed onto the surface of 
seeded agar. Spent broth samples from five strains were 
assayed on each plate. A control disc prepared using 
sterile MRS broth was also included on each plate. The 
plates were incubated 24 hours at 37°c. The plates were 
observed for zones of inhibition around each disc. 
Source and Maintenance of 
Selected Cultures 
Lactobacillus acidophilus RP32 and Lactobacillus 
acidophilus RP42 were obtained from the culture collection 
in the Dairy Foods Microbiology Laboratory at Oklahoma State 
University. The cultures were propagated weekly (1 percent 
inocula and 18 hr incubation at 37°c} in pepsinized milk 
nutrient (PMN) broth (46) and stored at 4°c between 
transfers. Cultures were subcultured at least three times 
just prior to use. 
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Culture Identity 
The identity of the two selected cultures was confirmed 
according to characteristics listed in the 8th edition of 
Bergey's Manual of Determinative Bacteriology (7) using the 
procedure of Gilliland and Speck (16). The substrates used 
for characterization were amygdalin, arabinose, arginine, 
cellobiose, esculin, galactose, glucose, lactose, maltose, 
mannitol, mannose, melezitose, melibiose, raffinose, 
rhamnose, salicin, sorbitol, sucrose, trehalose, and xylose. 
The ability to grow at 15 and 45°c as well as the Gram stain 
morphology were also examined. 
Preparation of Concentrated Cultures 
Cell crops of ~ acidophilus were grown in a 7-liter 
fermenter (New Brunswick Scientific Co., Edison NY) equipped 
with a combination pH electrode (Ingold Electrodes Inc., 
Wilmington MA). The crops were grown under constant 
agitation, pH, and temperature control. Broth temperature 
was controlled by immersing the fermenter in a water bath 
maintained at 37°c and pH was controlled by an automatic pH 
controller (New Brunswick Scientific Co., Edison NY). 
The fermenter jar containing 3-liters of distilled 
water was sterilized by heating 45 minutes at 121°c. The 
water was aseptically removed prior to the addition of the 
sterile growth medium. 
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Sterile PMN broth in 3 or 4 liter quantities was 
aseptically added to the fermenter and the temperature was 
adjusted to 37°c. The broth was adjusted to pH 5.0 with 
sterile 20 percent lactic acid before inoculation. The PMN 
broth was inoculated with 30-40 ml (1 percent) of a fresh 18 
hour PMN broth culture of the desired strain of L. 
acidophilus. The broth was maintained at pH 5.0 with a 20 
percent Na 2co3 in 20 percent NH 40H neutralizer (46) during 
growth of the cultures. 
The cell crop was removed, by vacuum, from the 
fermenter during the late exponential phase of growth (14-16 
hours) into 1-liter sterile filter flasks and placed in an 
ice water bath for one hour. The culture was then dispensed 
into 250 ml sterile centrifuge bottles and centrifuged at 
4080xg for 20 minutes at o-1°c in a Sorvall RC5 Superspeed 
Refrigerated Centrifuge (DuPont Co., Newtown CN). The 
supernatant was discarded and the cell pellets were 
resuspended in two times their weight of sterile 10 percent 
reconstituted nonfat milk solids with the aid of sterile 
glass beads (0.4 cm in diameter). The resulting 
concentrated culture was then dispensed in 2 gram quantities 
into sterile cryogenic vials (DynaTech Laboratories Inc., 
Chantilly, VA). After dispensing, the vials were frozen and 
stored at -196°c in liquid nitrogen. 
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Evaluation of Concentrated Cultures 
Numbers of lactobacilli were determined in the 
concentrated culture before freezing (day 0), at 24 hours 
post freezing (day 1) and at days 7, 14, 21, and 28 post 
freezing. The pour plate procedure using PMN and PMNO agars 
was employed. PMN agar was prepared by dissolving 1.5 
percent Bacto-Agar (Difeo) in PMN broth prior to sterilizing 
at 121°c for 15 min. PMNO agar (PMN agar + O.l percent 
oxgall; Difeo) was used to enumerate bile tolerant 
lactobacilli. 
For all enumeration procedures, 99 ml dilution blanks 
containing 0.1 percent Bacto-Peptone (Difeo) and 0.01 
percent Antifoam Emulsion A (Sigma Chemical Co., St. Louis, 
MO.) in distilled water were used. Initial 1:100 dilutions 
of concentrated cultures were made by adding 1 gram of 
concentrated culture to 99 ml of diluent. The vials of 
concentrated cultures were thawed by submerging each in 1-
liter of water at 25°c for five minutes. Prior to opening, 
the vials were immersed in 95% ethanol and excess alcohol 
was removed by wiping with a Kim-Wipe laboratory wipe 
(Kimberly Clark Corp., Roswell, GA.) 
Feeding Trial 1 ~esign 
Six week old Yorkshire gilts weighing between 8.85 and 
16.56 kg (avg=ll.48 kg) were assigned to four groups 
(6/group) based on litter number and weight. Litter mates 
were assigned to separate groups and the remaining animals 
were assigned so that each group had equal average weights. 
Each pig was housed in an individual pen. The pigs 
completed a seven day adjustment period prior to sta~ting 
the experimental period. During the adjustment period, the 
pigs received a 'diet without added cholesterol twice daily 
(Table II) and 50 ml of sterile reconstituted 10 percent 
nonfat milk solids (NFMS) daily. Initially, they received 
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0.091 kg of feed per feeding but that was increased to 0.181 
kg then to 0.272 kg per feeding as consumption needs 
increased during the adjustment period. 
For the experimental period, the four groups were 
randomly assigned to one of four treatments (Table I) 
consisting of two rations supplemented with fat and 
cholesterol, one with and one without whey (Table II). All 
pigs received 50 ml of 10 percent NFMS each day. The milk 
for each pig in one group receiving each ration was 
supplemented with 2.5xlo10 cells of ~· acidophilus RP32 and 
2.5xlo 10 cells of~· acidophilus RP42 per day. At the 
beginning of the experimental period, the pigs received 
0.408 kg of feed per feeding which increased as consumption 
needs increased. At the end of the trial, the pigs were 
receiving 0.862 kg feed per feeding. Any feed left two 
hours after each feeding was removed, weighed and the amount 
consumed was recorded. 
On days 0, 7, 14, 21, and 28, the pigs were weighed and 
blood samples were taken. 
Group 1 
Group 2 
Group 3 
Group 4 
TABLE I 
EXPERIMENTAL TREATMENTS FOR TRIAL I 
Nonwhey diet {S-244) and 50ml sterile 
10 percent NFMS 
Nonwhey diet {S-244) and SOml 10 percent 
NFMS containing 5xlo 10 cells of 
Lactobacillus acidophilusa 
Whey diet {S-245) and 50ml sterile 
10 percent NFMS 
Whey diet (S-245) and SOml 10 percent 
NFMS containing 5xlo 10 cells of 
Lactobacillus acidophilusa 
aThe milk was prepared by adding equal numbers 
of Lactobacillus acidophilus RP32 and Lactobacillus 
acidophilus RP42 from frozen concentrated cultures 
to steri!u 10 percent NFMS. The final concentration 
was SxlO cells per 50ml. 
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TABLE II 
PERCENTAGE COMPOSITION OF ADJUSTMENT 
AND TRIAL DIETS 
FOR TRIAL 1 
Adjustment diet 
Item S-237 
Corn 48.48 
Soybean Meal 28.62 
Whey 20.09 
Butter -----
Calcium Carbonate 0.73 
Dicalciurn Phosphate 1.46 
Vitamin Mineral TMa 0.38 
Salt 0.25 
Cholesterolb 
-----
Calculated composition 
Crude Protein 19.27 
Lysine 1.10 
Calcium 0.85 
Phosphorus 0.70 
Experimental 
S-244 
55.24 
33.50 
-----
7.50 
1.10 
1.85 
0.40 
0.25 
0.16 
19.63 
1.10 
0.91 
0.68 
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diets 
S-245 
17.49 
22.80 
50.00 
7.50 
0.60 
0.80 
0.40 
0.25 
0.16 
17.60 
1.10 
0.91 
8.68 
aSupplies 3628,874 IU vitamin A, 36,287.4 IU vitamin D, 
1542.2 IU vitamin E, 1814.4mg pantothenic acid, 2449.4mg 
niacin, 362.9mg riboflavin, 299.4mg menadione, 1.8mg 
vitamin B12 , 36,287.4mg chlorine, 8.2mg selenium, 2.3g 
Mn, 8.2g Zn, 8.2g Fe, 0.91g Cu, 16.3mg I per kilogram 
of vitamin-mineral TM 
b Purity at least equivalent to USP (Sigma Chemical Co St. 
Louis MO.) 
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Blood Collection and Analysis 
Venous blood samples (10 ml volume) were collected on 
the appropriate days after a 12 hour fast by vena cave 
puncture using the method described by Carle and Dewhist 
(8). Sterile 10 ml draw Vacutainers with no additives, 
fitted with 3.81 cm 20 gauge sterile needles (Becton 
Dickinson, Rutherford, NJ.), were used. Immediately 
following collection, the blood samples were chilled on ice 
for transportation to the laboratory. The samples were held 
four hours at 4°c then centrifuged at 3000xg for 10 minutes 
at 4°C using the Vacutainer tubes and Auto Iso-Filters (Clay 
Adams, Parsippany, NJ.). 
The serum was transferred to clean screw capped tubes 
and thoroughly mixed. Aliquots were removed for analysis 
and the remaining serum was frozen and stored in cryogenic 
vials (DynaTech Laboratories Inc., Chantilly, VA) at -20°c. 
The serum was immediately assayed for total cholesterol 
and HDL cholesterol using the enzymatic reagent kit ,from 
Sigma Chemical Co.(St. Louis MO.). A phosphotungstate 
precipitating reagent (Sigma Chemical Co. St. Louis MO.) was 
used in the HDL cholesterol analysis. The manual procedure 
for spectrophotometers requiring reaction volumes greater 
than 1 ml was used (58) • 
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Feeding Trial 2 Design 
Five week old Yorkshire gilts weighing 6.58 to 10.66 kg 
(avg=B.51 kg) were assigned to four treatment groups of five 
each (Table III) and housed as in the previous trial. The 
pigs had a seven day adjustment period prior to the start of 
the experimental period. Pigs in groups 1 and 2 received a 
diet without dried whey and those in groups 3 and 4 received 
the diet containing whey (Table. IV). They each received 
0.295 kg of the ration per feeding (two feedings per day). 
Additionally each animal was fed 50 ml of sterile 10 percent 
NFMS once daily. The adjustment rations for each group were 
the same as the experimental rations but did not contain 
added crystalline cholesterol. 
During the experimental period, the diets with added 
cholesterol were fed (Table IV). Pigs in all groups were 
also fed 50 ml 10% NFMS once daily just prior to the morning 
feeding. The milk for pigs in groups 2 and 4 was 
supplemented with 5xlo10 cells of L. acidophilus RP32 from 
concentrated cultures which had been stored at -196°c. 
During week 1 the pigs received 0.408 kg per feeding, in 
week 2, they received 0.499 kg per feeding and in week 3, 
they received 0.590 kg per feeding. Any feed left two hours 
after each feeding was removed and the amount consumed was 
determined and recorded. On days 0, 5, 10, 15, and 20, the 
pigs were weighed and blood samples were taken. 
Group 1 
Group 2 
Group 3 
Group 4 
TABLE III 
EXPERIMENTAL TREATMENTS FOR TRIAL 2 
Nonwhey diets (S-247) and 50ml 
sterile 10 percent NFMS 
Nonwhey diets (S-247) and 50ml 10 
percent NFMS containing 5xlo 10 cells 
of Lactobacillus acidophilus RP32a 
Whey diet (S-246) and SOml sterile 
10 percent NFMS 
Whey diet (S-246) and 50ml 10 
percent NFMS containing 5xlo 10 cells 
of Lactobacillus acidophilus RP32a 
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aThe milk was prepared by adding cells of Lactobacillus 
acidophilus RP32 from frozen concentrated cultures to 
steri0e 10 percent NFMS. The final concentration was 
5xl0 cells per 50ml. 
TABLE IV 
PERCENTAGE COMPOSITION OF ADJUSTMENT 
AND TRIAL DIETS FOR TRIAL 2a 
Item 
Corn 
Soybean Meal 
Whey 
Butter 
Calcium Carbonate 
Dicalcium Phosphate 
Vitamin Mineral TMb 
Salt 
Cholesterolc 
Calculated composition 
Crude Protein 
Lysine 
Calcium 
Phosphorus 
S-246 
42.48 
27 .oo 
20.00 
7.50 
0.90 
1.50 
0.40 
0.25 
0.16 
18.03 
1.04 
0.92 
0.69 
Diets 
S-247 
57.28 
31.40 
-----
7.50 
1.06 
1.95 
0.40 
0.25 
0.16 
18.88 
1.04 
0.92 
0.69 
aAdjustment rations were the same as the experimen-
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b tal diets but did not contain added cholesterol 
Supplies 3628,874 IU vitamin A, 36,287.4 IU vitamin D, 
1542.2 IU vitamin E, 1814.4mg pantothenic acid, 2449.4mg 
niacin, 362.9mg riboflavin, 299.4mg menadione, 1.8mg 
vitamin B12 , 36,287.4mg chlorine, 8.2mg selenium, 2.3g 
Mn, 8.2g Zn, 8.2g Fe, 0.9lg Cu, 16.3 mg I per kilogram 
of vitamin-mineral TM 
cPurity of at least USP (Sigma Chemical Co.,St. 
Louis MO.) 
Blood Collection and Analysis 
On the appropriate days, 10 ml venous blood samples 
were collected after a 12 hour fast, and prepared by the 
procedure used in the previous trial. After preparation, 
the serum was frozen in cryogenic vials at -20°c for later 
analysis. 
When the trial was completed, all samples for each 
animal were assayed together. Before analysis, the serum 
samples were thawed at room temperature and mixed a minimum 
of thirty seconds on a Vortex-Genie mixer (Scientific 
Industries Inc., Bohemia NY.) before dispensing for 
analysis. The samples were analyzed by the methods used in 
the previous trial. 
Statistical Analysis 
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Total and HDL serum cholesterol data as well as feed 
intake and pig weight data were analyzed using the general 
linear models procedure from the Statistical Analysis System 
(31). The least significant difference mean separation 
procedure was used to determine statistical significance 
among means of serum total and HDL cholesterol, feed intake 
and pig weights for the four treatment groups at the five 
sampling periods of each trial (62). Simple and partial 
correlation coefficients were determined to evaluate 
relationships among variables in the trials (62). 
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CHAPTER IV 
RESULTS 
Screening of Cultures 
The amounts of cholesterol assimilated by each of 14 
candidate strains of Lactobacillus acidophilus isolated from 
intestines of pigs are shown in Table v. The results are 
expressed as the amount (ug/ml) assimilated from the broth 
medium during 24 hours at 37°c. The strains varied 
substantially in their ability to remove cholesterol from 
the growth medium. Strains 1-3, RP32, RP42, and RP43 
exhibited the most uptake of cholesterol. Strain GP4A was 
the least active of the 14 strains. Other strains were 
intermediate. 
Strains GPlA, GP3A, RP32, and RP42 were the most bile 
resistant of the 14 strains tested in that they grew faster 
in MRS broth containing 0.3% oxgall (MRSO) than did the 
other strains (Table VI). This was indicated by the time 
needed for the growing culture to increase the absorbance of 
the growth medium by 0.3 units at 600 nanometers. Strains 
149C, A4, GPlA, and GP3A appeared to grow as well as or more 
rapidly in MRSO than in the control (MRS) broth. All the 
other strains tested appeared to be somewhat inhibited by 
TABLE V 
ASSIMILATION OF CHOLESTEROL BY SELECTED 
STRAINS OF LACTOBACILLUS ACIDOPHILUS 
Strain 
1-3 
149-C 
Al 
A3 
A4 
Cl-3 
Cl-6 
GPlA 
GP3A 
GP4A 
RP32 
RP34 
RP42 
RP43 
Cholesterol Assimilat~g 
(ug per ml of broth) 
93.8 
63.8 
29.0 
31.6 
28.2 
47.0 
35.4 
27.4 
38.8 
4.8 
87.4 
25.0 
94.2 
95.0 
aEach value is the average of three trials 
bDifference between cholesterol concentration in 
uninoculated control broth and in spent broth 
following 24 hours of growth of the test strain 
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TABLE VI 
BILE TOLERENCE OF SELECTED STRAINS 
OF LACTOBACILLUS ACIDOPHILUS 
Hours for Culture to Increase 
A600 by 0.3 Unitsa 
Control(MRS) MRS broth 
Strain broth +0.3% Oxgall 
• 
1-3 4.99 6.63 
149C 4.13 4.15 
Al 4.38 4.52 
A3 3.94 4.18 
A4 4.12 4.07 
Cl-3 3.97 5. 6 5 
Cl-6 5.40 >7.42b 
GPlA 4.45 3.92 
GP3A 4.02 3.80 
GP4A 4.17 4.52 
RP32 2.45 2.76 
RP34 4.23 >5.62 
RP42 3.37 3.66 
RP43 4.20 4.88 
~Each value is the average of three trials 
Readings were made at 0-8 hours. One or more 
value was greater than 8 hours in which case 
the value 8 was used to obtain the mean value 
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the presence of oxgall. Strains Cl-6 and RP34 were most 
sensitive to the bile. Strain RP32 which exhibited the most 
rapid growth of all strains in MRSO broth also grew fastest 
in MRS broth. However the rapidity of growth in the MRS 
broth was not a good predictor of rapidity of growth in MRSO 
broth. For example, strain Cl-3 which appeared to grow 
almost as rapidly as strain GP3A in MRS broth grew much 
slower than GP3A in MRSO broth. No clear association 
between bile resistance (Table VI) and ability to assimilate 
cholesterol (Table V) was indicated. 
All strains except 149-C produced some antagonistic 
action toward at least one other culture tested (Table VII). 
However~ strain 149-C was inhibited by spent broth from 8 of 
the other strains. Growth of strains 149-C, Cl-3, and Cl-6 
was inhibited by the majority of the other cultures 
indicating that these strains may be sensitive to the 
antagonistic action of a wide variety of strains of L. 
acidophilus. However none of the other strains tested were 
sensitive to spent broth from any of the 14 strains. 
Strains RP32 and RP42 were selected for use in pig 
feeding trials based on their bile tolerance, cholesterol 
assimilating ability and production of (or resistance to) 
antagonistic interactions with other strains. The identity 
characteristics of these two strains are listed in Table 
VIII. They were confirmed to be Lactobacillus acidophilus. 
Both exhibited differences in fermentation patterns but they 
more closely matched the characteristics of L. acidophilus 
Strain 
Tested for 
Sensitivity Code 
1-3 a 
149-C b 
Al c 
A3 d 
A4 e 
Cl-3 f 
Cl-6 g 
GPlA h 
GP3A i 
GP4A j 
RP32 k 
RP34 1 
RP42 m 
RP43 n 
a The spent broth 
- = presence of 
a 
+ 
+ 
TABLE VII 
DISC ASSAY TO TEST FOR INHIBITORY 
INTERACTIONS AMONG STRAINS OF 
LACTOBACILLUS ACIDOPHILUS 
Spent Broth pH 6.5a 
b c d e f g h i 
+ + + + + + 
+ + + + + 
+ + + + + 
j 
+ 
+ 
of each strain was assayed against each 
inhibition; + = absence of inhibition 
k 1 m n 
+ 
+ + + 
+ + + 
strain three times; 
TEST 
Gram Stain 
TABLE VIII 
IDENTITY CHARACTERISTICS OF 
LACTOBACILLUS ACIDOPHILUS 
CULTURES USED IN PIG 
FEEDING TRIALS 
Bergey' sa RP32 
+ + 
Cellular Morphology rods rods 
Catalase 
Growth at 1s0 c 
Growth at 4s0 c + + 
NH from Arginine 
Hydrolysis of Esculin + + 
Acid from: 
Amygdalin + + 
Arabinose 
Cellobiose + + 
Galactose + 
Glucose + + 
Lactose + + 
Maltose + + 
Marinitol 
Mannose + 
Melezitose 
Melibiose + + 
Raff inose + + 
Rhamnose 
Salicin + + 
Sorbitol 
Sucrose + + 
Trehalose + + 
Xylose 
a The characteristics of L. acidoJ2hilus as 
listed in Bergey's Manual of Determinative 
Bacteriology 8th edition. 
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RP42 
+ 
rods 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
listed in the 8th edition of Bergey's Manual of Determin-
ative Bacteriology (7) than any other species listed. 
33 
Strain RP32 differed in that it did not ferment galactose or 
mannose. Strain RP42 did not ferment amygdalin, mannose, 
salicin, or trehalose. 
The survivability of ~· acidophilus RP32 and RP42 in 
concentrated cultures is shown in Table IX. Neither strain 
exhibited much decline in total viability (PMN agar counts) 
over the 28 day storage period. There also was no appreci-
able decline in numbers of bile resistant lactobacilli (PMNO 
agar counts). Thus the cultures were stable in frozen 
storage at -196°c. 
Feeding Trial 1 
In trial 1, 24 six week old Yorkshire gilts were fed 
for 28 days on rations containing added cholesterol. Six 
animals were assigned to each of the 4 treatment groups 
(Table I). Animals in treatments 2 and 4 received 5xlo 10 
cells L. acidophilus per day. Animals in treatments 3 and 4 
received a 50% whey ration while those in treatments 1 and 2 
received a nonwhey ration. Both were corn and soybean meal 
based rations (Table II) • 
Blood samples were drawn at 7 day intervals during the 
trial for total and HDL serum cholesterol analysis. 
Cholesterol levels are expressed as mg cholesterol per lOOml 
serum (Tables X and XI). Serum total and HDL cholesterol 
levels in all treatment groups increased significantly by 
TABLE IX 
SURVIVAL OF LACTOBACILLUS ACIDOPHILUS 
RP32 AND RP42 IN CONCENTRATED 
CULTURES DURING STORAGE 
AT -196°C 
log10 CFU/g Concentrate 
L. acidophilus RP32a L. acidophilus RP42b 
Days at 
-196°C PMNc PMNOc 
0 10.45 + 0.44 10.42 + 0.42 
1 10.41 + 0 .42 10.40 + 0.40 
7 10.38 + 0.43 10.34 + 0.44 
14 10.48 + 0.42 10.41 + 0.39 
21 10.42 + 0.43 10.41 + 0.46 
28 10.53 + 0.38 10.53 + 0.37 
~ Each value is the mean from seven batches 
Each value is the mean from four batches 
10.35 + 0.11 10.32 + 0.09 
10.30 + 0.14 10.33 + 0.08 
10.32 + 0.09 10.29 + 0.08 
10.37 + 0.11 10.34 + 0.09 
10.30 + 0.05 10.29 + 0.05 
10.31 + 0.17 10.29 + 0.17 
c PMN = pepsinized milk nutrient agar; PMNO = PMN agar + 0.1% oxgall 
Treat-
ment 
1 
2 
3 
4 
83.35 
79.12 
80.77 
83.00 
0 
+ 13.24 
-
+ 8.50 
-
+ 6.33 
-
+ 9. 30 
-
TABLE X 
SERUM TOTAL CHOLESTEROL LEVELS 
AT SEVEN DAY INTERVALS 
FOR TRIAL 1 
mg Cholesterol/dl Seruma 
Days on Trial 
7 14 
96.20 + 13.51 104.50 + 6.29b 101.10 
- -
88.95 + 12.02 107.07 + 17.77b 102.00 
- -
88.75 + 12.29 110.26 + 19.47c 118.10 
- -
92.09 + 12.19 109.39 + 17.96c 119.26 
- -
21 28 
+ 10.41 140.43 + 17.35e 
- -
+ 17.49b 133.27 + 26.80e 
- -
+ 14.17d 138.26 + 20.37e 
- -
+ 22.68d 145.91 + 31. 86e 
- -
~cde Each value is a mean from six pigs + standard deviation 
Superscript indicates level of significant difference of the value from the day 0 
value. b = (P<0.05), c = (P<0.01), d = (P<0.001), e = (P<0.0001) 
w 
Ul 
0 
Treatment 
1 29.57 + 5.17 
-
2 31. 23 + 7. 65 
-
3 30.00 + 6.81 
-
4 32.00 + 6.00 
-
a 
TABLE XI 
SERUM HDL CHOLESTEROL LEVELS AT 
SEVEN DAY INTERVALS 
FOR TRIAL 1 
mg HDL Cholesterol/dl Serum a 
Days on Trial 
7 14 
32.88 + 6.07 37.00 + 3.03b 39.85 
- -
31.24 + 5. 22 40.64 + 4.39c 40.94 
- -
31.98 + 4. 5 7 38.25 + 6.20c 43.11 
- -
30.68 + 3. 65 39.89 + 4. 83b 42.25 
- -
21 28 
+ 4.67c 48.62 + 
- -
+ 4.85c 50.89 + 
- -
+ 7.20e 46.21 + 
- -
+ 6.28c 43.70 + 
- -
Each value is a mean from six pigs + standard deviation 
bcde Superscript indicates level of significant difference of the value from the 
day O value; b = (P<0.05), c = (P<0.01), d = (P<0.001), e = (P<0.0001) 
* Treatment values differ significantly (P<0.05) 
4.8e 
4.06e* 
4.17e 
4.40e* 
day 14 of the trial from a baseline value at day O. Serum 
total cholesterol levels were not significantly different 
among treatment groups at any of the 5 sampling periods 
(Table X) • There was a significant difference in serum HDL 
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cholesterol levels between groups 2 and 4 at day 28 (P<0.05) 
(Table XI) • There was considerable variation in serum total 
cholesterol levels within all the treatment groups as 
indicated by the large standard deviations. This large 
variation between individual pigs within each treatment 
group may have masked any differences due to the treatments. 
Pig weights did not differ significantly (P>0.05) among 
treatment groups at any of the 5 test periods of the trial 
(Table XII). Group means of pig weights did increase during 
each trial period however. 
Feed intake data for each 7 day period showed that feed 
intake was not significantly different (P>0.05) among the 4 
treatment groups. Group mean feed intake did increase 
throughout the trial (Table XIII). 
Simple correlation coefficients were determined for the 
variables in the trial (Table XIV). "Days on trial" was 
significantly correlated with pig weights, HDL and total 
serum cholesterol levels (P<0.0001). Total and HDL serum 
cholesterol levels were significantly correlated with pig 
weights (P<0.0001) and total serum cholesterol levels were 
correlated with HDL serum cholesterol levels (P<0.0001). 
Partial correlation coefficients were significant between 
total and HDL serum cholesterol (P<0.01), between pig 
0 
Treatment 
1 12.53 + 2.53 
-
2 12.64 + 2.26 
-
3 12. 76 + 1.90 
-
4 12.61 + 1. 77 
-
TABLE XII 
PIG WEIGHTS AT SEVEN DAY INTERVALS 
FOR TRIAL la 
Kg Bodyweightb 
Days on Trial 
7 14 
16.46 + 2.72 21.39 + 2.85 26.50 
- -
16.37 + 3.17 20.73 + 3.64 24.83 
- -
16.27 + 2.23 20.89 + 2.49 25.44 
- -
15.80 + 1.82 20.56 + 2.03 24.23 
- -
21 28 
+ 3.66 29.79 + 2.98 
- -
+ 4.16 28.77 + 4.40 
- -
+ 2.62 30.41 + 2.98 
- -
+ 1.91 29.39 + 2.02 
- -
~ Group means did not differ significantly between treatments at any sampling period. 
Each value is the mean value from six pigs + standard deviation 
w 
00 
Treat-
ment 
1 5.60 
2 4.98 
3 5. 3 3 
4 5.22 
TABLE XIII 
FEED INTAKE DURING SEVEN DAY 
INTERVALS FOR TRIAL la 
kg Feed Intake for 7 Day Periodb 
Days on Trial 
1-7 8-14 15-21 
+ 0.55 7.77 + o. 4 2 9.61 + 0. 3 7 
- - -
+ o. 82 6 .42 + 1.11 8.51 + 1.11 
- - -
+ o. 76 7. 0 6 + 1.04 9.09 + 0.99 
- - -
+ o. 7 4 6.82 + 1.08 B.53 + 1.19 
- - -
9.82 
9.25 
9.80 
9.11 
a Intake values did not differ significantly between 
the treatment groups in any of the trial periods 
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22-28 
+ 0. 8 2 
-
+ 0.80 
-
+ 0. 91 
-
+ 1.18 
-
any of 
b Each value is the mean from six pigs + standard deviation 
a 
Pig 
TABLE XIV 
SIMPLE CORRELATION COEFFICIENTS 
FOR TRIAL 1 
HDL Total 
Weights Cholesterol Cholesterol 
Days on 
0.899a 0.755a 0.719a Trial 
Feed Intake 0.117 0.074 0.098 
Total 
Cholesterol 0.663a 0.679a 1.000 
HDL 
Cholesterol 0.752a 1.000 
Pig Weights 1.000 
Values are significant (P<0.0001) 
Feed Days on 
Intake Feed 
0.070 1.000 
1.000 
weights and HDL serum cholesterol (P<0.01) and between pig 
weights and feed intake (P<0.05) (Table XV). 
Feeding Trial 2 
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Feeding trial 2 involved 20 five week old Yorkshire 
gilts. Five animals were assigned to each of the 4 
treatment groups (Table III) • Animals in treatment groups 1 
and 2 received a diet without whey and those in groups 3 and 
4 received a diet containing 20% whey. Both experimental 
diets contained added cholesterol (Table IV). Pigs in 
groups 2 and 4 also were fed 5xlo10 cells L. acidophilus 
RP32 per day. 
The pigs were on trial for 20 days and blood samples 
were taken at 5 day intervals. A significant increase in 
serum total cholesterol was not observed for any group 
during the trial nor were there any significant differences 
among treatments at any of the five sampling periods (Table 
XVI). An overall increase was not observed for HDL choles-
terol levels (Table XVII) • There was a significant 
difference between treatment groups 1 and 3 on day 15 of the 
trial (P<0.05). This, however, does not appear to indicate 
a trend towards consistent differences in serum HDL choles-
terol levels for the different treatment groups. 
Mean pig weights for each treatment group increased at 
each collection period (Table XVIII). The weights did not, 
Total 
Cholesterol 
HDL 
Cholesterol 
Pig 
Weights 
Feed 
Intake 
a Values b were Values were 
TABLE XV 
PARTIAL CORRELATION COEFFICIENTS 
FOR TRIAL 1 
Feed Pig HDL 
Intake Weights Cholesterol 
o.oso 0.106 0.289b 
-0.091 0.310a 1.000 
0.228b 1.000 
1.000 
significant (P<0.01) 
signigicant (P<0.05) 
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Total 
Cholesterol 
1.000 
0 
Treatment 
1 79.20 + 20.59 
-
2 76. 70 + 13.56 
-
3 76.95 + 21.97 
-
4 79.69 + 9.00 
-
TABLE XVI 
SERUM TOTAL CHOLESTEROL LEVELS 
AT FIVE DAY INTERVALS 
FOR TRIAL 2a 
Cholesterol/dl Serum b mg 
Days on Trial 
5 10 
73.64 + 19.78 80.84 + 44.17 
- -
72.24 + 8. 4 4 89.55 + 22.42 
- -
65.54 + 4.62 81.37 + 16.00 
- -
64.10 + 7.05 87.18 + 14.15 
- -
15 20 
81. 74 + 24.69 84.42 + 26.36 
- -
84.27 + 28.03 77.13 + 26.57 
- -
73.37 + 15.67 79.54 + 13.69 
- -
91. 78 + 19.45 90.28 + 13.85 
- -
a No significant increase from day 0 values occured nor were any significant differences 
between treatment group means observed at any of the sampling periods. 
b Each value is the mean from five pigs + standard deviation 
0 
Treatment 
1 32 .64 + 5.67 
-
2 28.75 + 6.24 
-
3 29.64 + 6.3 2 
-
4 27.23 + 6. 63 
-
a Each value is the mean 
TABLE XVII 
SERUM HDL CHOLESTEROL LEVELS AT 
FIVE DAY INTERVALS 
FOR TRIAL 2 
mg HDL Cholesterol/dl Serum a 
Days on Trial 
5 10 
31.44 + 5.96 32.32 + 6.75 36.62 
- -
30.02 + 5.21 36.52 + 4.33b 35.10 
- -
26.22 + 5. 6 2 32.08 + 5.36 28.10 
- -
26.52 + 4 .65 33.72 + 7.67 34.03 
- -
from five pigs + standard deviation 
15 
+ 7.78 
-
+ 5.43 
-
+ 6.61 
-
+ 5.62 
-
Superscript indicates level of significant difference of the value 
* value; b = (P<0.05), c = (P<0.01), d = (P<0.001), e = (P<0.0001) 
Treatment values differ significantly (P<0.05) 
20 
* 36.04 + 5.39 
-
32.91 + 7. 6 3 
-
* 31.10 + 5.38 
-
34.78 + 6.13 
-
from the day 0 
0 
Treatment 
1 8.32 + 1.53 
-
2 8.71 + 1.00 
-
3 8.66 + 1.13 
-
4 8.71 + 1.25 
-
TABLE XVIII 
PIG WEIGHTS AT FIVE DAY INTERVALS 
FOR TRIAL 2a 
Kg Bodyweightb 
Days on Trial 
5 10 15 
9.23 + 2.19 10.07 + 1.66 12.00 + 
- - -
9.00 + 1.42 10.07 + 1.57 11.32 + 
- - -
9.57 + 1.38 11.25 + 2.36 12.66 + 
- - -
9.93 + 1.29 11.11 + 2.39 12.86 + 
- - -
a Group means did not differ significantly between treatments 
b Each value is the mean from five pigs + standard deviation 
20 
1.52 15.56 + 1.85 
-
2.29 14.58 + 2.81 
-
1. 78 15.42 + 3.56 
-
2.65 16.74 + 2.86 
-
at any sampling period. 
however, differ significantly among treatment groups at any 
of the five weighing times. 
Feed intakes were not significantly different for any 
of the treatments during the four, five-day test periods 
(Table XIX). Feed intakes increased throughout the trial, 
however, they were far below the intakes observed in trial 
1. 
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In trial 2, days on trial were significantly correlated 
with pig weights (P<0.0001) and serum total cholesterol was 
correlated with HDL cholesterol levels (P<0.0001) (Table 
XX). Days on trial was negatively correlated with feed 
intake (P<0.0001). 
Significant partial correlation coefficients were found 
between HDL and total serum cholesterol (P<0.0001) and 
between feed intake and pig weights (P<0.05) (Table XXI). 
Serum total or HDL cholesterol were not significantly 
correlated with feed intake in either trial. This lack of 
correlation and the partial correlation coefficients suggest 
that factors other than feed intake may have had an effect 
on blood cholesterol levels. 
Treat-
ment 
1 1.47 
2 1. 51 
3 1. 73 
4 1.45 
TABLE XIX 
FEED INTAKE DURING FIVE DAY INTERVALS 
FOR TRIAL 2a 
kg Feed Intake for 5 Day Periodb 
Days on Trial 
1-5 6-10 11-15 
+ o. 81 2.22 + 0.59 3.18 + 0.86 4.27 
- - -
+ 0.24 2.20 + 0.94 2.87 + 1.06 3.69 
- - -
+ 0. 93 2.62 + 0.88 3.02 + 1.16 3.92 
- - -
+ o. 67 2.62 + 1.08 3.69 + 0.88 4.60 
- - -
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16-20 
+ 0.53 
-
+ 1.19 
-
+ 1.30 
-
+ 1.00 
-
a Intake values did not differ significantly between any of 
b the treatment groups in any of the trial periods 
Each value is the mean from five pigs ± standard 
deviation 
Days on 
Trial 
Feed Intake 
Total 
Cholesterol 
HDL 
Cholesterol 
Pig Weights 
TABLE XX 
SIMPLE CORRELATION COEFFICIENTS 
FOR TRIAL 2 
Pig HDL Total 
Weights Cholesterol Cholesterol 
0.740a 0.246 0.083 
-0.234 0.272 0.003 
0.118 0.702a 1.000 
0.181 1.000 
1.000 
a Values are significant (P<0.0001) 
Feed Days on 
Intake Feed 
-0.600a 1.000 
1.000 
TABLE XXI 
PARTIAL CORRELATION COEFFICIENTS 
FOR TRIAL 2 
HDL Total 
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Feed 
Intake 
Pig 
Weights Cholesterol Cholesterol 
Total 
Cholesterol 
HDL 
0.163 
Cholesterol -0.039 
Pig 
Weights 
Feed 
Intake 1.000 
0.099 
0.072 
1.000 
a Values were significant (P<0.0001). 
b Values were significant (P<0.05). 
1.000 
1.000 
CHAPTER V 
DISCUSSION 
There was much variation among the 14 cultures of ~· 
acidophilus tested in respect to bile tolerance, ability to 
assimilate cholesterol and production of (or resistance to) 
inhibition of other strains (Tables V, VI, VII). This 
emphasizes the need for careful culture selection. Just 
being a ~· acidophilus culture is not enough. Any culture 
selected as a dietary adjunct must have the properties to 
enable it to produce the desired function(s) in the host. 
Any strain of ~ acidophilus chosen for use as a dietary 
adjunct to lower serum cholesterol levels must possess 
certain characteristics. The culture must be able to 
survive and grow under conditions found in the intestine. 
It must be able to grow in the presence of bile (17) and be 
able to assimilate cholesterol under conditions likely to be 
found in the intestine (14). Furthermore it should not be 
easily inhibited by organisms occurring in the existing 
intestinal flora. Since L. acidophilus exhibits host 
specificity (13), any strain selected as an adjunct should 
be one capable of surviving and functioning in the desired 
host. Thus it should be one originally isolated from the 
specie for which it is to be used. Both strains selected in 
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this study were isolated from pig intestines. They were 
bile resistant and were not inhibited by other strains of L. 
acidophilus. They also produced maximal reductions in 
cholesterol concentrations in a laboratory growth medium. 
Both L. acidophilus and dietary whey have been shown to 
reduce blood cholesterol in animal models and in human 
infants. Gilliland et al.(14) were able to reduce serum 
cholesterol in growing swine by supplementing their diet 
with a cholesterol assimilating strain of L. acidophilus. 
In their report, variations in blood cholesterol levels 
among animals were much smaller within treatment groups (as 
indicated by group standard deviations) than in either trial 
in the present study. 
The high variations in blood cholesterol within 
treatment groups such as observed in the present study must 
be reduced in subsequent trials. The variation may have 
been caused by differences in the ages (Tables XXIII and 
XXV) and weights (Tables XII and XVIII) among animals at the 
start of the trials. Differences in feed intake and weight 
gains may produce individual variations in blood 
cholesterol levels. However, the lack of significant 
differences in either feed intake or pig weights among 
treatments suggests that this may not have occurred in the 
present study. Normal variation would be expected to occur 
within animals in each treatment group. However, the 
variations observed in the trial by Gilliland et al. (14) 
were much less than in the present study. 
S2 
Carroll and Hamilton (9) indicated that pigs undergo a 
reduction in plasma cholesterol within one week after 
weaning, however by the third week the cholesterol levels 
stabilize at near previous levels. Such a phenomenon may 
have influenced the results seen in the present trial. 
Early weaned pigs (3 weeks of age) do not appear to undergo 
as drastic a reduction (9). Since some of the animals in 
the second trial were less than five weeks old (Table XXV), 
this too may have influenced the results. 
Beames et al. (2) observed a trend towards lower blood 
cholesterol in growing swine consuming a ration containing 
SO% whey and O.S% cholesterol compared to pigs on a nonwhey 
ration which contained O.S% cholesterol. Using mature 
animals on an elevated cholesterol (O.S%) diet, Norton et 
al. (SO) were able to significantly decrease their serum 
cholesterol by supplementing the diet with 40% whey. 
Although total serum cholesterol was reduced, HDL serum 
cholesterol increased compared to animals on a control diet. 
Both trials in the present study as well as the work by 
Beames et al. (2) involved animals that were considerably 
younger than those used by Norton et al. (SO). Beames et 
al. (2) did not get a significant reduction in serum 
cholesterol levels as did Norton et al. (50), with the more 
mature animals. The reduction in serum cholesterol which 
can be achieved by adding whey in the diet may not be as 
pronounced in the younger, less mature animals. 
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Feed intake was much less for the smaller animals in 
the second trial than in the first which suggests that the 
animals may not have consumed enough of the diet containing 
cholesterol to produce an elevation in their cholesterol 
levels. The animals in the second trial were younger than 
those in the first. This may have adversely influenced 
their adaptation to the dry diet and thus resulted in 
greatly reduced feed intake. 
Weights of the pigs at the end of trial 1 were 10 kg 
greater than those at the end of the trial in the study by 
Gilliland et al. (14). Since the cell numbers of lacto-
bacilli fed daily were the same in both trials, the number 
fed may need to be increased as animal weight increases in 
order to produce the same response. Differences in growth 
rates of the young pigs may also be a factor. 
In order to use growing swine as an experimental 
model for cholesterol related studies, the model must be 
better defined. Studies need to be conducted to determine 
what levels of dietary cholesterol elicit a consistent 
increase in serum cholesterol levels among experimental 
animals. Excessive cholesterol intake most likely will 
negate detection of any positive responses due to 
consumption of cells of ~· acidophilus or dried whey. The 
level of whey intake required to produce a lowering response 
in the growing pig needs to be determined. Also, the 
optimum cell numbers of L. acidophilus needed daily should 
be determined. The many unanswered questions produced by 
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the present study point out the need for further research. 
A longer adjustment period following weaning for the younger 
animals may decrease their variability. Alternatively, 
mature animals (ie.full grown) may not express as much 
variability. Furthermore, such a nongrowing animal may more 
accurately model the adult human. 
CHAPTER VI 
SUMMARY AND CONCLUSIONS 
Elevated levels of serum cholesterol are considered one 
of the major risk factors contributing to coronary heart 
disease. Consumption of either cells of L. acidophilus or 
dairy whey has been shown to limit increases in blood chol-
esterol levels in animals on a high cholesterol diet. A 
further understanding is needed to determine if these 
methods of dietary supplementation would provide an alterna-
tive method for individuals to control elevated blood chol-
esterol levels. The purpose of this study was to evaluate 
the young growing pig as a model to determine the singular 
and combined effects of consuming cells of L. acidophilus 
and dried sweet dairy whey on serum cholesterol levels. 
Fourteen strains of ~· acidophilus were screened as 
candidates to use as adjuncts in pig feeding trials. 
Strains RP32 and RP42 were chosen because they more actively 
assimilated cholesterol from a growth medium and were more 
bile resistant than other strains tested. Furthermore, they 
were resistant to antagonistic inhibition produced by other 
strains of L. acidophilus tested. 
Supplementation of the diet with cells of L. acid-
ophilus, dried whey, or a combination of the two did not 
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influence elevated serum cholesterol levels of six week old 
pigs on a high cholesterol diet. Five week old pigs used in 
a similar trial on a high fat and cholesterol diet without 
~· acidophilus or whey did not exhibit an increase in blood 
cholesterol as expected. Supplementation of the younger 
pig's diet with whey or L. acidophilus RP32 did not cause a 
reduction in blood cholesterol levels. Excessive variation 
in blood cholesterol levels for pigs in each treatment group 
in both trials likely concealed any effects due to treat-
ments. Because the younger pigs either did not exhibit an 
increase in blood cholesterol levels or exhibited excessive 
variation among animals, they may not be a model for 
cholesterol related studies. 
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APPENDIX A 
ASSIGNMENT AND AGE OF PIGS 
IN TRIAL 1 
.63 
Treatment 1 
Ear Notch 
Pig no Litter Ind 
1 83 - 1 
8 78 - 9 
13 82 - 1 
16 78 -11 
17 81 - 9 
24 77 -11 
TABLE XXII 
ASSIGNMENT OF PIGS TO TREATMENTS 
FOR TRIAL 1 
Treatment 2 Treatment 3 
Ear Notch Ear Notch 
Pig no Litter Ind Pig no Litter Ind 
2 82 - 5 4 78 - 4 
3 83 - 4 7 80 - 0 
5 77 - 9 9 83 - 2 
14 78 - 5 11 4 - 6 
15 4 - 5 12 82 - 3 
20 81 -11 18 81 -13 
Treatment 4 
Ear Notch 
Pig no Litter Ind 
6 78 - 7 
10 78 - 6 
19 82 - 2 
21 80 - 5 
22 81 -14 
23 83 - 4 
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TABLE XXIII 
AGE OF PIGS USED IN TRIAL 1 
Days of age at 
Beginning of Number of pigs 
Litter No. Birth Date Adjustment period In Trial 
77 5-19-1986 53 2 
78 5-21-1986 51 6 
80 5-27-1986 45 2 
81 5-28-1986 44 4 
83 5-30-1986 42 4 
82 5-30-1986 42 4 
4 6-05 1986 36 2 
APPENDIX B 
ASSIGNMENT AND AGE OF PIGS 
IN TRIAL 2 
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Treatment 1 
Ear Notch 
Pig no Litter Ind 
1 55 - 3 
3 52 - 7 
5 55 - 9 
9 54 -11 
13 53 - 6 
TABLE XXIV 
ASSIGNMENT OF PIGS TO TREATMENTS 
FOR TRIAL 2 
Treatment 2 Treatment 3 
Ear Notch Ear Notch 
Pig no Litter Ind Pig no Litter Ind 
7 54 -13 6 53 - 9 
8 52 -10 11 54 -12 
10 57 -10 15 53 - 7 
14 55 -10 17 57 - 9 
22 53 - 8 19 52 - 8 
Treatment 4 
Ear Notch 
Pig no Litter Ind 
4 54 -10 
12 57 - 8 
16 53 - 4 
18 58 8 
20 52 - 6 
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TABLE XXV 
AGE OF PIGS USED IN TRIAL 2 
Days of age at 
Beginning of Number of pigs 
Litter No. Birth Date Adjustment period In Trial 
52 9-03-1986 41 4 
53 9-04-1986 40 5 
54 9-06-1986 38 4 
55 9-09-1986 35 3 
57 9-12-1986 32 3 
58 9-12-1986 32 1 
APPENDIX C 
INDIVIDUAL PIG DATA 
FOR TRIAL 1 
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TABLE XXVI 
INDIVIDUAL PIG DATA FOR TRIAL 1 
Day Total HDL 
Pig of Treat- Chol- Chol- Pig Feed 
No. Trial rnent esterol esterol Weights Intake 
1 0 1 77.02 29.81 17.01 
2 0 2 69.19 25.29 10.77 
3 0 2 91. 16 40. 15 16.56 
4 0 3 86.62 37.68 13.15 
5 0 2 82.83 35.73 13.15 
6 0 4 82.58 30.16 11.68 
7 0 3 89.90 32.72 11. 57 
8 0 1 73.99 28.39 11. 34 
9 0 3 78.03 34.05 16.33 
10 0 4 82.83 41.13 12.70 
11 0 3 73.23 31. 31 11. 00 
12 0 3 76.52 25.47 r2. 02 
13 0 1 72.73 24.15 10.09 
14 0 2 84.09 36.35 13.27 
15 0 2 70.45 30.07 10.32 
16 0 1 97.98 38.21 13.83 
17 0 1 86.11 24.85 10.89 
18 0 3 80.30 18.75 12.47 
19 0 4 86.87 33.17 11.34 
20 0 2 77.02 19.81 11. 79 
21 0 4 98.48 35.20 . 12.02 
22 0 4 73.48 28.83 11. 79 
23 0 4 73.74 23.53 16.10 
24 0 1 104.29 32.02 12.02 
l 7 1 84.14 29.60 20.87 5.15 
2 7 2 85. 93 27.90 14.29 4.48 
3 7 2 85. 68 35.03 21. 09 5.56 
4 7 3 91.18 35.22 17.12 5.84 
5 7 2 104.22 39.00 18.37 5.99 
6 7 4 80.56 25.22 15.54 5.87 
7 7 3 106.65 37.22 16.56 5.95 
8 7 1 104.73 38.66 15.99 5.99 
9 7 3 71. 87 32.88 19.73 5.66 
10 7 4 86.70 33.83 15.99 5.48 
11 7 3 84. 02 33.64 13. 15 4.04 
12 7 ·3 81. 59 27.37 14.74 4.75 
13 7 1 80.05 26.35 13.15 4.65 
14 7· 2 83.38 32.66 17.35 5.41 
15 7 2· 72.51 27.45 12.36 3.77 
16 7 1 112.40 41.68 17.69 5.82 
17 7 1 88.87 28.39 14.29 5.61 
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TABLE XXVI (Continued) 
Day Total HDL 
Pig of Treat- Chol- Chol- Pig Feed 
No. Trial ment esterol esterol Weights Intake 
18 7 3 97.19 25.52 16.33 5.71 19 7 4 106.91 30.92 13.27 3.98 20 7 2 101. 92 25.41 14.74 4.67 21 7 4 103.07 34.01 16.22 5.71 22 7 4 97.70 27.33 14.97 5.62 23 7 4 77.62 32.77 18.82 4.68 24 7 l 107.03 32.58 16.78 5.95 1 14 1 94.21 36.86 25.40 7.98 2 14 2 125.07 40.58 17.46 4.96 3 14 2 . 99. 45 41.82 25.17 7.36 4 14 3 115. 98 47.77 21.21 6.90 5 14 2 133.33 46.75 24.49 7.98 6 14 4 86.64 33.73 20.98 7.88 7 14 3 131. 54 41. 91 22.34 7.94 8 14 1 110.61 36.60 21. 43 7.95 9 14 3 95.73 37.59 24.27 7.89 10 14 4 96.28 44.14 20.41 6.69 11 14 3 88.29 38.91 17.24 5.27 12 14 3 96.69 31.93 18.94 6.58 13 14 1 106.06 37.07 17°.80 6.92' 14 14 2 95. 73 40.71 21. 77 6.41 15 14 2 88.98 40.92 16.56 5.56 16 14 1 105.92 42.55 22.91 7.90 17 14 1 100.14 35.45 18.48 7.98 18 14 3 133.33 31. 38 21. 32 7.79 19 14 4 120.52 38.87 17.12 4.96 20 14 2 99.86 33.05 18.94 6.25 21 14 4 134.71 43.54 21. 32 7.14 22 14 4 118. 04 34.72 20.19 7.82 23 14 4 100.14 44.31 23.36 6.44 24 14 1 110. 06 33.48 22.34 7.87 1 21 1 98.55 45.26 30.62 10.0l 2 21 2 121.49 41. 68 22.00 7.78 3 21 2 105.79 43.47 30. 16 9.97 4 21 3 110. 58 46.53 26.08 8.85 5 21 2 122.49 42.40 29.03 9.41 6 21 4 97.33 37.07 24.95 10.14 7 21 3 137.86 39.12 27.22 9. 94 8 21 l 100.11 37.16 25.40 9.43 9 21 3 106.79 50.54 28.58 9.7E 10 21 4 121. 05 51. 90 24.04 8.59 11 21 3· 102.23 50.63 21.55 7.52 12 21 3 131.29 38.78 23.13 8.49 13 21 1 114. 48 42 .19 22.23 8.96 
- -------
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TABLE XXVI (Continued) 
Day Total HDL 
Pig of Treat- Chol- Chol- Pig Feed 
No. Trial ment esterol esterol Weights Intake 
14 21 2 93.76 45.09 25.63 8.83 
15 21 2 81. 29 41. 59 19.73 6.93 
16 21 1 89.98 43.68 27.22 9.84 
17 21 l 90.98 32.86 22.91 9.78 
18 21 3 119. 82 33.07 26.08 9.97 
19 21 4 114. 59 37.24 20.87 7. 11 
20 21 2 87.19 31. 41 22.45 8.17 
21 21 4 158.80 48. 32· 25.17 8.52 
22 ~.1 4 125.95 39.29 23.81 9.52 
23 21 4 97.88 39.67 26.54 7.35 
24 21 1 112.47 37.93 30.62 9.66 
1 28 l 125.70 42.93 33.57 8.60 
2 28 2 175.58 55.45 24.72 8.32 
3 28 2 126.98 52.36 33.68 8.48 
4 28 3 133.12 47.79 29.82 8.84 
5 28 2 145.40 53.71 33.57 10.42 
6 28 4 118.16 40.64 29.82 11. 20 
- 7 28 3 165.73 52.70 33.34 10.58 8 28 1 135.17 47.75 28.80 9.81 
9 28 3 121. 48 47.71 33.34 10.56 
10 28 4 123.40 42.42 28.80 8.86 
11 28 3 112. 02 45.08 25.86 8.78 
12 28 3 141. 18 43.18 28.35 9.34 
13 28 1 146.04 50.50 25.86 9.97 
14 28 2 123.66 51. 81 30.05 9.78 
15 28 2 94.25 47.24 24.04 9.01 
16 28 1 132.23 54.64 31.87 10.65 
17 28 1 130.43 43.27 27.22 9.16 
18 28 3 156.01 40.77 31. 75 10.69 
19 28 4 178.13 48.38 26.42 8.58 
20 28 2 133.76 44.79 26.54 9.46 
21 28 4 182.48 48.85 30.96 9.72 
22 28 4 161.64 37.60 28.24 8.19 
23 28 4 111. 64 44.28 32.09 8.08 
24 28 1 173.02 52.61 31. 41 10.69 
APPENDIX D 
INDIVIDUAL PIG DATA 
FOR TRIAL 2 
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TABLE XXVII 
INDIVIDUAL PIG DATA FOR TRIAL 2 
Day Total HDL 
Pig of Treat- Chol- Chol- Pig Feed 
No. Trial roent esterol esterol Weights Intake 
1 0 1 91. 27 35.04 8.85 
1 5 1 73.50 28.93 9.07 0.56 
1 10 1 79.96 30. 93 . 9.41 1. 39 
1 15 1 95.48 40.98 11.34 2.45 
1 20 1 94.68 36.46 15.54 4.28 
7 0 2 58.05 21. 21 8.28 
7 5 2 74.81 31. 61 8.96 1. 69 
7 10 2 110.17 35.28 11. 34 3.41 
7 15 2 77.28 31. 23 12.70 3.56 
7 20 2 51. 02 24.35 16.10 5.03 
6 0 3 58.18 24.01 8.16 
6 5 3 68.32 26.43 8.85 1. 33 
6 10 3 107.63 34.40 9.19 1. 96 
6 15 3 69.59 26.60 9.07 1. 37 
6 20 3 87.72 30.25 11. ll 1. 81 
4 0 4 79.39 32.30 8.16 
4 5 4 60. 15 29.11 10.55 2.09 
4 10 4 70.32 24.86 10.66 2.77 
4 15 4 87.12 31. 36 .10.55 3.42 
4 20 4 74.27 33.36 14.52 3.27 
3 0 1 62.00 35.67 7.48 
3 5 l 60.50 36.62 9.19 2.04 
3 10 1 43.60 29.04 10.77 2.89 
3 15 1 55.41 31. 02 13.61 4.64 
3 20 l 71.89 34.99 16.78 5.12 
8 0 2 93.19 37.73 9.53 
8 5 2 63.08 34.91 11.34 1. 81 
8 10 2 63.40 32.67 13.27 2.58 
8 15 2 72.17 35.74 14.63 4.37 
8 20 2 51. 72 25.61 18.82 4.73 
11 0 3 48.48 22.96 7.82 
11 5 3 64.54 31.48 9.64 1. 96 
11 10 3 64. 16 27.47 10.09 2.66 
11 15 3 48.13 19.81 12.47 3.22 
11 20 3 55.69 23.67 15.54 4.6 
12 0 4 64.37 28.78 9.07 
12 5 4 63.98 28.02 9.30 1. 05 
12 10 4 94.23 41. 80 10.09 2.06 
12 15 4 100.92 42.30 12.25 3.36 
12 20 4 106.88 45.42 16.44 4.63 
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TABLE XXVII (Continued) 
Day Total HDL 
Pig of Treat- Chol- Chol- Pig Feed 
No. Trial ment esterol esterol Weights Intake 
5 0 1 52.75 23.65 7.48 
5 5 1 56.05 24.67 8.05 1. 25 
5 10 1 43.76 24.25 9.30 2.04 
5 15 1 71. 08 35.98 10.43 2.68 
5 20 1 65.47 37.34 14.17 4.01 
10 0 2 73.05 31.67 9.98 
10 5 2 85.10 34.31 8.96 1. 45 
10 10 2 67.09 33.45 8.73 0.85 
10 15 2 61.25 29.27 10.32 1. 91 
10 20 2 83.71 41. 92 12.70 2.23 
16 0 3 96.46 37.75 8.39 
15 5 3 70 .. 66· 29.'.17 8 .. 39 0.68 
15 lo· 3 78.83 39. 99 . 11.5'1 2.07 
15 15 3 88.48 37.34 12.81 2.82 
15 20 3 83.54 29.90 15.08 3.71 
16 0 4 85.10 16.11 7.37 
16 '& 4 76.11 30.28 8. "39 0.89 
16 10 4 99.78 38.25 8.39 1.07 
16 15 4 ·59_.59 30.81 l'0.77 2.56 
16 20 4 85.30 32.52 14.06 3.97 
9 0 1 89.63 30.·78 7.03 
9 5 1 71.69 28.25 7.03 0.96 
9 10 l 85.15 35.32 8.28 2.14 
9 15 l 69.14 27.80 10.55 3-.26 
9 20 l 63.94 28.18 13.38 3.1 
14 ·o 2 73.05 26.38 8.16 
14 5 2 71.30 26.32 7.94 1.36 
14 10 2 105.20 43.42 7.94 1.96 
14 15 2 77.65 35.93 9.75 2.42 
14 20 2 84.71 35.38 13.04 3.61 
17 0 3 89.45 33.85 8.28 
17 5 3 65.48 26.50 9.07 1.53 
17 10 3 75.82 27.06 10.21 2.3 
17 15 3 78.65 31.36 12.25 3.04 
17 20 3 89.27 ·33. 25 14.40 4.25 
18 0 4 82.85 32.13 8.28 
18 5 4 62.04 26.64 9.64 1.75 
18 10 4 73.45 26.20 11.57 3.42 
18 15 4 82.49 28.49 13.72 4.31 
18 20 4 82.45 29.63 17.46 5.4 
13 0 1 100.33 38.05 10.77 
13 5 1 106.50 38.71 12.81 2.55 
13 10 1 151. 72 42.08 12.59 2.66 
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TABLE XXVII (Continued) 
Day Total HDL 
Pig of Treat- Chol- Chol- Pig Feed 
No. Trial ment esterol esterol Weights Intake 
13 15 l 117.58 47.30 14.06 2.89 
13 20 1 126.13 43.21 17.92 4.28 
22 0 2 86.16 26.75 7.60 
22 5 2 66.91 22.96 7.82 1.24 
22 10 2 101. 87 37.77 9.07 2.31 
22 15 2 132.99 43.35 9.19 2.08 
22 20 2 .. 114.50 37.30 12.25 2.87 
19 0 3 92.16 29.62 10.66 
19 5 3 58.78 16.94 11.91 3.81 
19 10 3 80.39 31.46 15.20 4.12 : 
19 15 3 82.00 25.35 16.67 4.65 
19 20 3 81.49 38.43 20.98 5.26 
20 0 4 86.74 26·. 87 10.66 
20 5 4 58.23 18.57 11. 79 2.46. 
20 10 4 98.13 37.50 14.86 3. 77 . 
20 15 4 119.78· 37.17 17.01 4. 81 . 
20 20 4 102.49 32.97 21.21 5.71 
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